Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Mdck-derived Cell Lines Adapted To Serum-free Culture And Suspension Culture And Method For Preparing Vaccine Virus Using The Cells

一种无血清培养基、悬浮培养的技术，应用在制备疫苗病毒领域，能够解决致瘤性危险、培养过程复杂等问题，达到极低致瘤性的效果

Active Publication Date: 2015-08-26
SK BIOSCI CO LTD
View PDF4 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The second method has the defect that the cultivation process is relatively complicated
Therefore, there is a risk of potential tumorigenicity when using the original MDCK cell line for vaccine production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mdck-derived Cell Lines Adapted To Serum-free Culture And Suspension Culture And Method For Preparing Vaccine Virus Using The Cells
  • Mdck-derived Cell Lines Adapted To Serum-free Culture And Suspension Culture And Method For Preparing Vaccine Virus Using The Cells
  • Mdck-derived Cell Lines Adapted To Serum-free Culture And Suspension Culture And Method For Preparing Vaccine Virus Using The Cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Prepare the cell line derived from MDCK by serum-free culture and suspension culture

[0035] CCL-34 in MDCK cell line provided by ATCC. In T-25 flasks, in EMEM medium supplemented with 10% serum at 37 °C and 5% CO 2 CCL-34 was cultured under. After cell expansion, the cells were cultured in a medium consisting of EMEM medium and serum-free medium (50%). During the culture process, confirm whether the growth of the cells is normal. When normal cell growth was confirmed, the grown cells were cultured in a medium containing serum-free medium (75%). This process was repeated to obtain cell lines adapted to serum-free medium (100%). EX-CELL MDCK (Sigma), UltraMDCK (Lonza) and VP-SFM (Invitrogen) can be used as medium for serum-free culture.

[0036] Cell lines adapted to serum-free media were extensively expanded in T-flasks. Then, in a spinner flask (Corning) at 37 °C and 5% CO 2 The expanded cell line was adapted to suspension culture with agitation at a rate of 4...

Embodiment 2

[0037] Evaluation of Cell Line Proliferation Potential

[0038] The prepared MDCK-derived cell lines cultured in a serum-free medium were cultured under the conditions shown in Table 1. The proliferative potential of MDCK-derived cell lines was assessed. MDCK cell line (ATCC CCL-34) was cultured in medium supplemented with 10% serum as a negative control.

[0039] Table 1

[0040] [Table 1]

[0041] [surface]

[0042]

[0043] At the beginning of the culture, the cell culture concentration was about 1.0×10 5 cells / ml. When the cell concentration reaches about 1×10 6 cells / ml or after 3-4 days of culture, the cells were passaged. Adjust the cell concentration at the initial stage of subculture to 1×10 5 cells / ml.

[0044] Each of the MDCK-derived cell lines grown in serum-free media exhibited comparable cell growth rates to MDCK cells grown in serum media.

Embodiment 3

[0045] Evaluation of proliferation curve and passage stability of cell lines

[0046] After adaptation to serum-free culture and suspension culture, the three cell lines were further cultured in spinner flasks, and their proliferation curves and passage stability were evaluated. Adjust the concentration of cells at the initial stage of culture to approximately 4×10 5 cells / ml. After about 3-4 days of culture, the cell concentration reached about 2×10 6 cells / ml or more. Culture was performed under the following conditions. The result is as figure 1 shown.

[0047] Starting cell concentration: 4 x 10 5 cells / ml

[0048] Culture scale: 50ml spinner bottle

[0049] Spinner rotation rate: 60rpm

[0050] Culture conditions: 37°C, 5% CO 2 , wet

[0051] Subculture conditions: 3-4 days after culture

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed is a Madin-Darby canine kidney (MDCK)-derived cell line. The MDCK-derived cell line is derived from MDCK cells deposited under accession number ATCC CCL-34. The MDCK-derived cell line can be prepared by serum-free culture and suspension culture. Preferably, the MDCK-derived cell line has low or no tumorigenicity. The MDCK-derived cell line is preferably selected from MDCK Sky1023, MDCK Sky10234 and MDCK Sky3851. Further disclosed are a culture method for growing the MDCK-derived cells and a method for producing a vaccine virus using the MDCK-derived cells.

Description

[0001] This application is a Chinese invention patent application with the application number 201180042923.8, the application date is September 06, 2011, and the title is "A cell line derived from MDCK adapted to serum-free culture and suspension culture and a method for preparing vaccine virus using the cell" divisional application. technical field [0002] The present invention relates to a new MDCK-derived cell line (MDCK-derived cell line), the MDCK-derived cell line can be prepared by serum-free culture and suspension culture and does not need to be attached to carriers (carriers), the preparation of the A method for MDCK-derived cell lines, and a method for preparing vaccine viruses using said MDCK-derived cell lines. Background technique [0003] Fertilized eggs, mouse brain, primary cells, and established cell lines are commonly used as sources for vaccine preparation. However, there are many problems with this traditional source of vaccines. For example, when tryi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/071C12N7/00A61K39/145A61P31/16C12R1/91C12R1/93
CPCA61K39/12C12N2500/90C12N2760/16252A61K39/145C12N5/0686A61K2039/5254C12N2760/16134C12N7/00C12N2760/16234C12N2760/16152A61P31/12A61P31/16Y02A50/30A61K39/00C12N5/06C12Q1/02A61K2039/525C12N2760/16151C12N2760/16171C12N2760/16251C12N2760/16271
Inventor 朴容郁李建世李峰镛朴万勋金勋金允熙李受陈
Owner SK BIOSCI CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com